Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000574784 | SCV000670693 | uncertain significance | Hereditary cancer-predisposing syndrome | 2020-02-04 | criteria provided, single submitter | clinical testing | The p.G1135A variant (also known as c.3404G>C), located in coding exon 13 of the PALB2 gene, results from a G to C substitution at nucleotide position 3404. The glycine at codon 1135 is replaced by alanine, an amino acid with similar properties. This amino acid position is well conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Baylor Genetics | RCV004569236 | SCV005055049 | uncertain significance | Familial cancer of breast | 2023-11-13 | criteria provided, single submitter | clinical testing | |
Clinical Genetics Laboratory, |
RCV004696950 | SCV005197070 | uncertain significance | not provided | 2023-03-02 | criteria provided, single submitter | clinical testing |